Leptin Replacement Therapy Drastically Reduces Triglyceride Levels and Controls Diabetes in Certain Patients
Leptin replacement therapy drastically reduces triglyceride levels and controls diabetes in patients with lipodystrophies.
New Cholesterol Guidelines Released
The National Cholesterol Education Program (NCEP) issued major new clinical practice guidelines on the prevention and management of high cholesterol in adults. The guidelines are the first major update from NCEP in nearly a decade.
Research Suggests Vitamin D Supplements Do Not Improve Cholesterol as Previously Thought
Vitamin D has been touted for its positive effects on a range of human systems, from enhancing bone health to reducing the risk of developing certain types of cancer.
Derivative of the Green Tea Leaf May Help With Metabolic Syndrome X
Metabolic Syndrome X is the term used to describe a group of heart disease risk factors.
Extended-Release Niacin Effective in Low Doses for Diabetics
Niacin, a medication once discouraged for the treatment of lipid abnormalities in patients with diabetes, has the potential ability, when given in low doses, to be well-tolerated and effective.
Fish Oil and Red Yeast Rice Studied for Lowering Blood Cholesterol
Researchers examine whether an alternative approach to treating high blood cholesterol may provide an effective treatment option for patients who are unable or unwilling to take statins.
Metabolic Syndrome Linked to Cold Tolerance
Researchers have discovered that many of the genetic variations that have enabled human populations to tolerate colder climates may also affect their susceptibility to metabolic syndrome.
Statin Therapy Cuts Bad Cholesterol Unprecedented 70-Percent
Research shows that a combination statin therapy lowers bad cholesterol by an unprecedented 70 percent, and has the added benefit of reducing life-threatening inflammation that can lead to heart disease and stroke.
No Good Evidence That Cholesterol Drugs Lower Melanoma Risk
No clear evidence exists that some widely-prescribed cholesterol-lowering drugs can decrease the risk of melanoma, a deadly and malignant skin cancer, according to a new review of recent studies.
Fat in the Liver, Not the Belly, is a Better Marker for Disease Risk
New findings suggest that it's not whether body fat is stored in the belly that affects metabolic risk factors for diabetes, high blood triglycerides and cardiovascular disease, but whether it collects in the liver.
Researcher Breaks Down Cholesterol Mystery
Scientist: chylomicrons gather on arterial walls and may be as dangerous or more dangerous than low-density lipoprotein (LDL) cholesterol in causing strokes and heart attacks.
Widely Used Cholesterol Medicine May Increase Muscle Pain
Up to 75-percent of patients who take a widely used cholesterol medicine to treat high cholesterol may end up suffering from muscle pain.
Higher Oxidized LDL Levels Linked to Increased Risk of Metabolic Syndrome
Higher concentrations of low-density lipoprotein (LDL) that has been modified by oxidation is associated with an increased incidence of abdominal obesity, high fasting glucose levels and high triglyceride levels and the metabolic syndrome, which includes a combination of these conditions.
Study Reinforces Link Between Obesity, High-Fat Meals and Heart Disease
The effect of a high-fat meal on blood vessel walls can vary among individuals depending on factors such as their waist size and triglyceride levels.
Diabetes Medication May Help Slow Plaque Build-up in Coronary Arteries
A comparison of two types of medications to treat type 2 diabetes finds that pioglitazone is more effective at lowering the rate of progression of plaque build-up in the coronary arteries than glimepiride, according to a study in the April 2 issue of JAMA.
Common Heart Drug’s Link to Diabetes Found by Researchers
Researchers may have found a novel way to suppress the devastating side effect of one of the worlds' most widely used drugs to lower cholesterol and prevent heart disease.
